AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents

Not Applicable

Completed

Conditions: Cognitive Change
Cannabis Use
Adolescent Behavior

Interventions: Behavioral: Abstinence

First Posted Date: 2017-09-08

Last Posted Date: 2024-02-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 201

Registration Number: NCT03276221

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.

Phase 1

Terminated

Conditions: Melanoma

Interventions: Drug: Trametinib
Drug: Dabrafenib
Drug: INCB039110

First Posted Date: 2017-09-05

Last Posted Date: 2023-09-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1

Registration Number: NCT03272464

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients

Recruiting

Conditions: Breast Cancer Stage III
Breast Cancer Stage II

First Posted Date: 2017-09-01

Last Posted Date: 2023-09-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT03270072

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play

Not Applicable

Conditions: Aggression
Anger

Interventions: Behavioral: Relaxation training plus Sham Videogame
Behavioral: Relaxation training plus RAGE-Control

First Posted Date: 2017-09-01

Last Posted Date: 2020-07-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT03270813

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use

Phase 4

Conditions: Surgery
Opioid-use Disorder
Pain, Acute

Interventions: Drug: buprenorphine/naloxone

First Posted Date: 2017-08-30

Last Posted Date: 2018-10-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 76

Registration Number: NCT03266445

Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease

Not Applicable

Completed

Conditions: Crohn Disease
Ulcerative Colitis
Inflammatory Bowel Diseases

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Probiotic Mixture

First Posted Date: 2017-08-30

Last Posted Date: 2025-05-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT03266484

Locations: 🇺🇸
Crohn's and Colitis Center, MGH, Boston, Massachusetts, United States

Evaluation of PET/MR in Patients Selected for Ablation Therapy

Phase 2

Active, not recruiting

Conditions: Arrhythmias, Cardiac

Interventions: Drug: 18F-TPP

First Posted Date: 2017-08-29

Last Posted Date: 2024-01-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 34

Registration Number: NCT03265431

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging

Recruiting

Conditions: Coronary Artery Disease
Myocardial Ischemia

Interventions: Diagnostic Test: Single-Scan Two-Injection Protocol

First Posted Date: 2017-08-29

Last Posted Date: 2023-04-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT03265535

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Phase 2

Terminated

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Humalog
Drug: BC222 insulin lispro
Drug: Novolog
Device: Bionic Pancreas

First Posted Date: 2017-08-25

Last Posted Date: 2022-12-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT03262116

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Validation of Thermal Imaging to Detect Pneumonia

Terminated

Conditions: Pneumonia

Interventions: Diagnostic Test: Thermal image

First Posted Date: 2017-08-25

Last Posted Date: 2020-11-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT03261479

Locations: 🇺🇸
Ryan MD Carroll, Boston, Massachusetts, United States

Home Terms & Conditions Privacy Policy